References
- TsochatzisEABoschJBurroughsAKLiver cirrhosisLancet201438399301749176124480518
- Abd-ElsalamSSharaf-EldinMSolimanSEfficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practiceArch Virol20181631515628983675
- AhmedOAKaisarHHHawashNEfficacy of sofosbuvir plus ribavirin with or without peginterferon-Alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infectionInfect Disord Drug Targets20171729510028413993
- AhmedOAElsebaeyMAFouadMHAOutcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infectionInfect Drug Resist20181144144529628768
- AhmedOAKaisarHHBadawiREfficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infectionInfect Drug Resist20181129529829535545
- ZhouGWTaoZYPengCHLiHWReasonable choice of surgical procedures for patients with portal hypertensionHepatobiliary Pancreat Dis Int20032333033314599933
- GroszmannRJAbraldesJGPortal hypertension: from bedside to benchJ Clin Gastroenterol2005394 Suppl 2S12515758647
- D’AmicoGGarcia-TsaoGPagliaroLNatural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studiesJ Hepatol200644121723116298014
- GuevaraMCárdenasAUrizJGinèsPPrognosis in patients with cirrhosis and ascitesGinèsPArroyoVRodésJSchrierRWAscites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis and TreatmentMaldenBlackwell2005260270
- Sharaf-EldinMBediwyASKobtanAPigtail catheter: a less invasive option for pleural drainage in Egyptian patients with recurrent hepatic hydrothoraxGastroenterol Res Pract201620164013052401305527340399
- ElfertAAbo AliLSolimanSIbrahimSAbd-ElsalamSRandomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitisEur J Gastroenterol Hepatol201628121450145427512927
- RunyonBAIntroduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012Hepatology20135741651165323463403
- BhogalHSanyalAJTreatment of refractory ascitesClin Liver Dis201323140142
- WongFNadimMKKellumJAWorking Party proposal for a revised classification system of renal dysfunction in patients with cirrhosisGut201160570270921325171
- HäussingerDKircheisGFischerRSchliessFvom DahlSHepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?J Hepatol20003261035103810898326
- YeeHFLidofskySDAcute liver failure7th edFeldmanMFried-manLSSleisengerMHSleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, ManagementPhiladelphiaSaunders2002567574
- KatanMMüllerBChrist-CrainMCopeptin: a new and promising diagnostic and prognostic markerCrit Care200812211711818355399
- ChikanzaICPetrouPChrousosGPerturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implicationsAnn N Y Acad Sci200091782583411268412
- MorgenthalerNGStruckJJochbergerSDünserMWCopeptin: clinical use of a new biomarkerTrends Endocrinol Metab2008192434918291667
- AwayaHMitchellDGKamishimaTHollandGItoKMatsumotoTCirrhosis: modified caudate-right lobe ratioRadiology2002224376977412202712
- AngeliPMerkelCPathogenesis and management of hepatorenal syndrome in patients with cirrhosisJ Hepatol200848Suppl 1S93S10318304678
- SalernoFGerbesAGinèsPWongFArroyoVDiagnosis, prevention and treatment of hepatorenal syndrome in cirrhosisGut20075691310131817389705
- CholongitasEPapatheodoridisGVVangeliMTerreniNPatchDBurroughsAKSystematic review: The model for end-stage liver disease–should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis?Aliment Pharmacol Ther20052211–121079108916305721
- SolàEMoreiraRRodriguezE605 Plasma copeptin levels are increased in cirrhosis and correlate with hyponatremia and circulatory dysfunctionJ Hepatol201358S247S407
- MorenoJPGrandclementEMonnetEPlasma copeptin, a possible prognostic marker in cirrhosisLiver Int201333684385123560938
- KimerNGoetzeJPBendtsenFMøllerSNew vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory stateEur J Clin Invest201444544145224476551
- BallSGVasopressin and disorders of water balance: the physiology and pathophysiology of vasopressinAnn Clin Biochem200744Pt 541743117761027
- KimWRBigginsSWKremersWKHyponatremia and mortality among patients on the liver-transplant waiting listN Engl J Med2008359101018102618768945
- CoenraadMJde RooijBJVerbruggenLvan HoekBvan der ReijdenJJVerspagetHW619 Copeptin; An independent prognostic factor in cirrhosis?J Hepatol2012562S245S246